Antivir Ther

• 

  Publication Venue For

  • Socioeconomic status largely explains integrase inhibitors-related body composition differences in chronically infected men living with HIV..  27:13596535221109748. 2022
  • Assessing bias introduced in estimated glomerular filtration rate by the inhibition of creatinine tubular secretion from common antiretrovirals..  25:287-292. 2020
  • Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015..  23:363-372. 2018
  • Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon..  22:179-184. 2017
  • Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings..  22:205-213. 2017
  • Research in action: from AIDS to global health to impact. A symposium in recognition of the scientific contributions of Professor Joep Lange..  20:101-108. 2015
  • The clinical management of HCV in the HIV-infected patient..  20:457-467. 2015
  • Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals..  18:785-791. 2013
  • Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients..  18:793-802. 2013
  • Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C..  17:1189-1199. 2012
  • HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam..  17:905-913. 2012
  • Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients..  16:1341-1346. 2011
  • Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy..  16:591-596. 2011
  • CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials..  15:351-361. 2010